$22.80
-0.50-2.15%
Last update: Nov 5, 10:00 AM
Alto Neuroscience Inc (ANRO) Stock Price, Quote, News & History
ANRONYSE
Alto Neuroscience acquires Chase's treatment-resistant depression drug portfolio for $1.75 million upfront; early data shows strong efficacy for lead candidate...
You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.
Other companies in Alto Neuroscience’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Alto Neuroscience has a consensus price target of $30.55.
The stock price for Alto Neuroscience (NYSE: ANRO) is $22.8 last updated November 5, 2026 at 10:00 AM EST.
There are no upcoming dividends for Alto Neuroscience.
Alto Neuroscience does not have any upcoming earnings scheduled.
There is no upcoming split for Alto Neuroscience.
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different...
